Cymbiotics, Inc. – Trademark Portfolio

Entity Type: 03

Cymbiotics, Inc. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FLEXASUR and CETOSOMES. The owner is based in Escondido, CA.

29268 Meadow Glen Way - West

Escondido, CA 92026

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Cymbiotics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (18 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Cymbiotics, Inc. have?

Cymbiotics, Inc. has 20 U.S. trademarks filed with the USPTO. Of these, 2 registered, 17 abandoned, 1 cancelled.

What trademark classes does Cymbiotics, Inc. file in?

Cymbiotics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Cymbiotics, Inc.'s most well-known trademarks?

Cymbiotics, Inc.'s registered trademark portfolio includes well-known marks such as FLEXASUR and CETOSOMES. These are among 2 currently registered trademarks in the portfolio.

What is Cymbiotics, Inc.'s trademark registration success rate?

Cymbiotics, Inc. has a 10% trademark registration rate, with 2 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.